Former Rio boss heads to Vedanta

The UK-listed mining company, along with analysts, have welcomed his appointment.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Former Rio Tinto (ASX: RIO) Chief Executive, Tom Albanese, has been appointed chairman of Vendanta Resources.

A UK-listed company, Vendanta is primarily focused on projects in India although it has numerous operations throughout the world, including a copper mine in Tasmania. Mr Albanese has been appointed to the leadership position of the company's wholly owned subsidiary, Vedanta Resources Holdings Limited.

According to the company he will look to drive growth through strategy and policy but primarily focus on Vedanta's Zambian projects, which include several copper facilities.

Mr Albanese served as Rio Tinto CEO for six years until he stepped down earlier this year after significant writedowns amounting to $14 billion. The writedowns followed from a number of poor purchases including its aluminium and Mozambique coal businesses – the biggest writedowns ever in the industry. Starting in 1993, Mr Albanese quickly rose the ranks to CEO and oversaw the $37.1 billion purchase of Canada's Alcan and $3.7 billion purchase of Mozambique's Mining Limited in 2011.

Analysts at Citigroup welcomed the appointment by saying "as Mr Albanese being a geologist, not only brings in his technical expertise but also the experience of leading a company like Rio Tinto, which is well regarded for its best practices in running the assets. This is likely to improve VED's image as a more sustainable, development-oriented organisation".

Interested in our #1 dividend stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »